NASDAQ
CytoDyn Inc. (CYDY) has a free cash flow growth of -26.87% as of Friday, May 29, 2026. This represents a 46.68% decrease compared to its 12-month average of -18.32%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.